These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38818692)

  • 1. Comparison of EsophyX2.0 and MUSE systems for transoral incisionless fundoplication: Technical aspects and outcomes up to 3 years.
    Testoni SGG; Pantaleo G; Contu F; Azzolini F; Fanti L; Testoni PA
    Dig Endosc; 2024 May; ():. PubMed ID: 38818692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transoral incisionless fundoplication with Medigus ultrasonic surgical endostapler (MUSE) for the treatment of gastro-esophageal reflux disease: outcomes up to 3 years.
    Testoni SGG; Cilona MB; Mazzoleni G; Fanti L; Ribichini E; Cavestro GM; Esposito D; Viale E; Notaristefano C; Zuppardo RA; Azzolini F; Passaretti S; Testoni PA
    Surg Endosc; 2022 Jul; 36(7):5023-5031. PubMed ID: 34799745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transoral incisionless fundoplication for recurrent symptoms after laparoscopic fundoplication.
    Ghosh G; Choi AY; Dbouk M; Greenberg J; Zarnegar R; Murray M; Janu P; Thosani N; Dayyeh BKA; Diehl D; Nguyen NT; Chang KJ; Canto MI; Sharaiha R;
    Surg Endosc; 2023 May; 37(5):3701-3709. PubMed ID: 36650353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The long-term efficacy of transoral incisionless fundoplication with Medigus Ultrasonic Surgical Endostapler (MUSE) for gastroesophageal reflux disease.
    Shen S; Yu G; Guo X; Zong G; Wang C; Bao J; Chen J; Cheng Z; Xiao W; Shen J; Jiang W; Wan R
    Esophagus; 2023 Jul; 20(3):581-586. PubMed ID: 36877412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transoral incisionless fundoplication effective in eliminating GERD symptoms in partial responders to proton pump inhibitor therapy at 6 months: the TEMPO Randomized Clinical Trial.
    Trad KS; Barnes WE; Simoni G; Shughoury AB; Mavrelis PG; Raza M; Heise JA; Turgeon DG; Fox MA
    Surg Innov; 2015 Feb; 22(1):26-40. PubMed ID: 24756976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response of Laryngopharyngeal Symptoms to Transoral Incisionless Fundoplication in Patients with Refractory Proven Gastroesophageal Reflux.
    Snow GE; Dbouk M; Akst LM; Ihde G; Zarnegar R; Janu P; Murray M; Eskarous H; Sohagia A; Dhar SI; Irene Canto M
    Ann Otol Rhinol Laryngol; 2022 Jun; 131(6):662-670. PubMed ID: 34378427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The TEMPO Trial at 5 Years: Transoral Fundoplication (TIF 2.0) Is Safe, Durable, and Cost-effective.
    Trad KS; Barnes WE; Prevou ER; Simoni G; Steffen JA; Shughoury AB; Raza M; Heise JA; Fox MA; Mavrelis PG
    Surg Innov; 2018 Apr; 25(2):149-157. PubMed ID: 29405886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laparoscopic Hiatal Hernia Repair Followed by Transoral Incisionless Fundoplication With EsophyX Device (HH + TIF): Efficacy and Safety in Two Community Hospitals.
    Janu P; Shughoury AB; Venkat K; Hurwich D; Galouzis T; Siatras J; Streeter D; Korman K; Mavrelis G; Mavrelis P
    Surg Innov; 2019 Dec; 26(6):675-686. PubMed ID: 31431138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized controlled trial of transoral incisionless fundoplication vs. proton pump inhibitors for treatment of gastroesophageal reflux disease.
    Witteman BP; Conchillo JM; Rinsma NF; Betzel B; Peeters A; Koek GH; Stassen LP; Bouvy ND
    Am J Gastroenterol; 2015 Apr; 110(4):531-42. PubMed ID: 25823768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term efficacy of transoral incisionless fundoplication with Esophyx (Tif 2.0) and factors affecting outcomes in GERD patients followed for up to 6 years: a prospective single-center study.
    Testoni PA; Testoni S; Mazzoleni G; Vailati C; Passaretti S
    Surg Endosc; 2015 Sep; 29(9):2770-80. PubMed ID: 25480624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term benefit of transoral incisionless fundoplication using the esophyx device for the management of gastroesophageal reflux disease responsive to medical therapy.
    Stefanidis G; Viazis N; Kotsikoros N; Tsoukalas N; Lala E; Theocharis L; Fassaris A; Manolakopoulos S
    Dis Esophagus; 2017 Feb; 30(3):1-8. PubMed ID: 27868281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transoral incisionless fundoplication demonstrates durability at up to 9 years.
    Bell RCW; Freeman K; Heidrick R; Ayazi S
    Therap Adv Gastroenterol; 2021; 14():17562848211004827. PubMed ID: 33948113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transoral incisionless fundoplication (TIF 2.0) with EsophyX for gastroesophageal reflux disease: long-term results and findings affecting outcome.
    Testoni PA; Vailati C; Testoni S; Corsetti M
    Surg Endosc; 2012 May; 26(5):1425-35. PubMed ID: 22170317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transoral incisionless fundoplication with an ultrasonic surgical endostapler for the treatment of gastroesophageal reflux disease: 12-month outcomes.
    Testoni PA; Testoni S; Mazzoleni G; Pantaleo G; Cilona MB; Distefano G; Fanti L; Antonelli M; Passaretti S
    Endoscopy; 2020 Jun; 52(6):469-473. PubMed ID: 32187630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of transoral incisionless fundoplication for refractory gastroesophageal reflux disease: a systematic review and meta-analysis.
    McCarty TR; Itidiare M; Njei B; Rustagi T
    Endoscopy; 2018 Jul; 50(7):708-725. PubMed ID: 29625507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of transoral incisionless fundoplication on symptoms, PPI use, and ph-impedance refluxes of GERD patients.
    Testoni PA; Corsetti M; Di Pietro S; Castellaneta AG; Vailati C; Masci E; Passaretti S
    World J Surg; 2010 Apr; 34(4):750-7. PubMed ID: 20091308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-year results of a feasibility study on antireflux transoral incisionless fundoplication using EsophyX.
    Cadière GB; Van Sante N; Graves JE; Gawlicka AK; Rajan A
    Surg Endosc; 2009 May; 23(5):957-64. PubMed ID: 19288158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antireflux transoral incisionless fundoplication using EsophyX: 12-month results of a prospective multicenter study.
    Cadière GB; Buset M; Muls V; Rajan A; Rösch T; Eckardt AJ; Weerts J; Bastens B; Costamagna G; Marchese M; Louis H; Mana F; Sermon F; Gawlicka AK; Daniel MA; Devière J
    World J Surg; 2008 Aug; 32(8):1676-88. PubMed ID: 18443855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Laparoscopic Nissen Fundoplication vs Transoral Incisionless Fundoplication or Proton Pump Inhibitors in Patients With Gastroesophageal Reflux Disease: A Systematic Review and Network Meta-analysis.
    Richter JE; Kumar A; Lipka S; Miladinovic B; Velanovich V
    Gastroenterology; 2018 Apr; 154(5):1298-1308.e7. PubMed ID: 29305934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective multicenter registry of patients with chronic gastroesophageal reflux disease receiving transoral incisionless fundoplication.
    Bell RC; Mavrelis PG; Barnes WE; Dargis D; Carter BJ; Hoddinott KM; Sewell RW; Trad KS; DaCosta Gill B; Ihde GM
    J Am Coll Surg; 2012 Dec; 215(6):794-809. PubMed ID: 22939637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.